CTRI/2019/11/021895尚未招募3 期
An Open Label Non Randomized Clinical Trial to Evaluate the Efficacy of Homoeopathic medicine in reducing the Anti Cyclic Citrullinated Peptide Levels in Rheumatoid Arthritis
Hafsa Muhammed0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Cases with Anti CCP above 20 IU/ml
- •Cases fulfilling the diagnostic criteria of rheumatoid arthritis
排除标准
- •Patients with any known serious co-morbities of Rheumatoid Arthritis
- •Patients on NSAIDs/DMARDs
- •Rheumatoid Arthritis associated with complicated systemic disease
- •Pregnant women and lactating mothers
- •Immuno compromised patients
研究者
相似试验
尚未招募
2 期
Effect of Patola-Nimbadi Basti in the Management of Psoriasis w.s.r. to EkakushthaCTRI/2024/06/069477Institute for Ayurved Studies and Research Umri Road Kurukshetra Haryana
进行中（未招募）
不适用
Homoeopathy in the treatment of PsoriasisCTRI/2022/04/041787ational Institute of Homoeopathy
招募中
4 期
Intravitreal Aflibercept for the Treatment of Treatment Resistant Macular Oedema secondary to Retinal Vein Occlusionsmacular oedema secondary to retinal vein occlusionACTRN12617001487303A/Prof Andrew Chang50
已完成
2 期
Safety assessment of inhaled RESP301 in patients with pulmonary tuberculosisFully sensitive multidrug-resistant tuberculosisInfections and InfestationsTuberculosisISRCTN14833199Thirty Respiratory Limited10
进行中（未招募）
不适用
A prospective, open label, monocenter trial to evaluate the interaction between the Platelia Aspergillus ELISA test and the administration of piperacillin/tazobactam.Evaluation of interference between platelia aspergillus ELISA TEST and administration of PIPERACILLIN/TAZOBACTAM.MedDRA version: 6.1Level: HLGTClassification code 10004018EUCTR2004-001321-25-ITWYETH LEDERLE